Military doctors faced a critical challenge for many years: What is the perfect method to provide patients in distant combat zones, rural hospitals or areas affected by disasters safely and effectively?

Oxygen tanks are heavy in combat zones, expensive and dangerous. A direct hit from a rocket or a ball can turn a life -saving resource right into a fatal danger.

marine Gen. Ernest T. Cook once said“Logistics is the difficult part of the war.” It goes beyond oxygen. For the US troops used, the soldiers who’re wounded within the fight for treatment can mean the difference between life and death.

The Ministry of Defense turned to us, military doctors and academic researchers in military medicine on the Colorado Center for Combat Research on the University of ColoradoTo study whether the military has to bring oxygen to the battlefield for soldiers – and in that case, how much.

This research approach is referred to as a military-civil partnership. These partnerships aim to save lots of lives on the battlefield. But additionally they save lives within the United States by transforming military medical gains into higher health look after everyone.

Innovation and mobility

In the civilian world it takes Average 17 years So that a research discovery changes medical practice. One of essentially the most famous examples of that is using tranexamic acid for trauma patients. Tranexamic acid is injected to stop bleeding During the operation or after the trauma. It was discovered in 1962, but was only approved by the FDA in 1986. was not used for traumatic bleeding Until 2012.

The change in war and threats to US forces require military medicine to drag faster. Injuries and infections within the fight, researchers urge higher opportunities to save lots of lives, often faster than in civilian health care.

Scientists work in the middle Side by side with military medical teams Studying, developing and testing solutions which are tailored to the battlefield.

Whether it’s address oxygen consumptionPresent Traumatic brain injuriesburning treatments or Trauma careThese partnerships enable military and civil researchers to quickly implement discoveries into practice.

Rethink oxygen

The Immediate administration of oxygen For an injured or sick patient, there has long been a cornerstone of trauma and fire care. The logic seemed easy to be: If patients are shocked or serious injuries have severe injuries, their bodies have difficulty getting enough oxygen in order that the doctors made available extra.

Our research and others found that an excessive amount of Oxygen can actually be harmful. Excess oxygen triggers oxidative stress – an overload of unstable molecules which are known as free radicals can damage healthy cells. This can result in more inflammation, slower healing and even organ failure.

In short, although oxygen is important, more just isn’t all the time higher.

We have carried out quite a lot of collaborative legal proceedings entitled “Military Civilian” Strategy to avoid excessive oxygen or save-o2. We discovered that seriously injured patients often need less oxygen believed than previously believed. In fact, little or no additional oxygen is required to securely take care of 95% of those patients.

This statement questions many years of conventional medical wisdom. It will probably be redesigned how medical specialists not only approach critical care in military environments, but additionally in civilian hospitals.

Within a yr of Present our results of medical leadersThese findings have already got Exhibitions and updates for the patient influence Nursing guidelines, Medic training and even decisions concerning the purchases of medical devices.

To construct on our findings, we began a study to look at using Artificial intelligence to automate oxygen delivery. This study, financed by the military, could higher provide wounded soldiers in distant combat zones and injured civilians in ambulances or rural hospitals before reaching major transfers and trauma centers.

In rural or distant areas of the United States, access might be limited to supplementary oxygen as a consequence of challenges of the provision chain, high costs and deficiency. That is Especially in small hospitals And affects first aiders after a natural disaster or an accident. In the intensive care units of those hospitals, using oxygen could receive efficiently restricted oxygen supply for patients who need it.

Longer accident supply: a brand new border

During the research of oxygen needs in combat zones, we were recognized one other urgent problem: the challenges of an extended accident supply. During a conflict, military doctors often should treat critically injured soldiers for hours and even days before the wounded person might be evacuated.

In a future conflict with a “near -peer” epee similar to China or Russia, the United States may not have the flexibility to quickly evacuate wounded troops. Without a reliable helicopter or aircraft transport, many victims may not reach trauma care Within the “golden hour. ““ This is the critical first 60 minutes after a serious injury if a fast treatment is important.

The ongoing war in Ukraine shows the Challenge of an extended accident supply. In hospitals in all Ukraine, doctors have increasingly difficulty treating the injuries of civil and military patients as a consequence of civil and military patients Increasing antibiotic resistance.

Future military conflicts within the Indopazacific regions can be found Similar challenges, including long patient traffic times and concerns regarding wound infections as a consequence of longer accident care.

However, this challenge just isn’t just on the battlefield. An extended accident supply also takes place in civil crises. For example, rescue staff should manage patients without quick access to hospitals during a natural disaster.

As soon as patients are treated on site or in disaster scenarios, providers must often be supplied with limited resources. You should prioritize essential interventions, minimize resource use and stabilize patients for the ultimate transfer to a better level of care.

Innovations in healthcare live from cooperation. Military-civil partnerships are a method to promote medical solutions faster and more effectively. These innovations save life in combat, improve care and enable us to use our application 98% survival rate within the war To our trauma centers, rural hospitals and disaster zones within the USA

A very good sleep is usually the stage for a positive day. But for that Almost quarter From American adults who must cope with mental illnesses Good night peace is usually difficult to know.

In patients with psychiatric diseases of Seeks To Mood disorders Like depression, disturbed sleep can often worsen the symptoms and make it harder to stick with treatment.

Despite the vital role of Zirkadian rhythms and sleeping game in addiction, Neuroscientists like me Only now begin to grasp the molecular mechanisms behind these effects.

Sleep and addictive drugs have one tangled relationship. Most addictive medication can change sleep-wake cycles, and sleep disorders in individuals who use drugs are related to the severity and relapse of the addiction. While this has a classic dilemma “chicken-or-EGG”, it also offers the chance to grasp how the Sleep-Diction connection could unlock recent treatments.

Circadian rhythms and health

At the middle of the connection between sleep and mental health is circadian rhythms: the interior clock of your body.

These rhythms align their body functions with their surroundings and synchronize their body day and night to the molecular level. This is completed by quite a few proteins that interact in a feedback loop and switch genes on and off in regular patterns to support specific functions. Although your sleep-wake cycles are essentially the most visible expression of circadian rhythms, these rhythms are Orchestrating most of your physiology.

If you may have ever traveled in time zones, you may have probably experienced a typical type of a circadian disorder as jet lag. This misalignment affects your sleep and concentration and might feel irritated.

While jetlag is a short lived annoyance, chronic circadian disorders can result in long -term health consequences, including an increased risk of Cardiovascular diseases and diabetes.

Circadian rhythms, sleep and opioid consumption

A essential focus of My laboratory Is on opioid dependency, an illness that nearly claimed 80,000 have been living per yr since 2021 within the USA and only has limited treatment options.

People who’re hooked on opioids Your sleep And theirs Corticotropin levelA key hormone that regulates stress. These disorders are related to many negative health consequences. In the short term, these disorders can affect Cognitive functions corresponding to attention and increase negative emotions. This will be done over time worsen mental and physical health. Studies on opioid dependency in mice show similar Disruptions in sleep And Different hormonal rhythms.

It is very important that poor sleep is common throughout the experience of an individual with opioid usage disorders, from energetic use to retreat from opioids and even during treatment. This complication can have profound consequences. Studies have associated the sleep problem with A 2.5 times increased risk of relapse Among those that treat themselves.

Turn off the clock for opioid dependency

Using the brain tissue of deceased donors and experiments in mice, my team identifies molecular changes related to psychiatric disorders in humans. We model these changes in mice to look at how they influence the severity and behavior of the disease.

Through genetic sequencing and computer modeling, my laboratory can profile all RNA molecules in a brain region and understand how their rhythmicity – the height and lows of their activity changes over the day – as a consequence of opioids. This provides a whole snapshot from which genes change in order that my team can integrate into the molecular mechanics that may advance the opioid dependency.

For example, we checked out two brain regions which are strongly connected to addiction: the Nucleus Accumbens and the Dorsolateral Prefrontal Cortex. We found that patients with opioid dependency had complete Different gene expression patterns In these brain regions in comparison with those without addiction. Some genes had taken over a very different rhythm of activity, while others had lost their rhythmicity as a complete.

Gene that lost the rhythm included those that were involved in various components of the molecular watch, and people related to the duration of sleep. This also shows how a circadian disorder is a symptom of opioid consumption and at the identical time reveals its underlying mechanisms.

In work that’s pending, my team focused on a big gene that lost the rhythmicity in patients with opioid dependency: NPAS2. This component of the molecular clock is extremely energetic and vital for the Nucleus Accumbens Sleep and circadian regulation. We found that the blocking of the functional NPAS2 Increased fentanylseecing behavior In mice. Interestingly, we observed that female mice were able to press a lever more often than male mice to get fentanyl what was documented Gender differences in opioid dependency Among people. In one other study we also found that the shortage of NPAS2 was lacking Worsened sleep disorders For mice that Fentanyl was administered.

Together, our results increase the role that Zirkadiane rhythms play in addiction. Future work can make clear whether the targeting of NPAS2 could treat opioid dependence symptoms. With prime quality sleep, it's not nearly waking up refreshed, but additionally for a reduced use of opioids and fewer overdoses.

As space travel gains traction and astronauts spend increasing amounts of time in space, studying health effects becomes more critical.

Is space travel really secure? Far from it – research has shown that the results of space radiation and microgravity on the human body are each harmful and long-lasting. However, creating space conditions on Earth could potentially help researchers treat cancer.

We are Biomedical engineers Study what the body is like Cells change under microgravity. By mimicking Earth's microgravity conditions, researchers can study their effects without space travel.

Laboratory research in space

Microgravity is a condition by which gravity is amazingly weak and objects are almost weightless. This happens in space, where Earth's gravity rarely affects astronauts.

It could be a microgravity environment for an prolonged time frame Multiple health problemsincluding bone loss, muscle weakness, facial swelling and heart changes. Even after astronauts return to Earth, their bodies Don't go completely back to normal.

By studying how cells, organs and tissues reply to microgravity, scientists can higher understand easy methods to address associated harmful changes to the body. By conducting research on laboratory samples in space faces significant challenges.

It is pricey to launch devices and samples, and experiments have to be planned around weightless conditions and launch force. Strict deadlines, limited access to space missions, and reliance on astronauts to conduct experiments increase the complexity of those studies, making rigor and collaboration critical to success.

Accessing samples after they’ve been sent into space can be difficult. They risk being damaged during harsh space conditions and through transport back to Earth.

The planning means of planning and conducting a laboratory study in space will be time-consuming and limit the practicality of frequent experiments.

Study of microgravity on Earth

To address these problems, scientists have developed devices that may simulate microgravity conditions on Earth.

This is such a tool Knocksa machine that repeatedly rotates to mimic the results of low gravity. By continuously rotating, it distributes the results of gravity evenly in order that the sample is “weightless,” or near it. To mimic the results of microgravity, the clinostat must turn around Just the fitting speed – fast enough that the sample doesn’t reply to gravity, but not so fast that it feels other strong forces.

Another method called dielectrophoresis Places particles like cells in a non-uniform electric field. Unlike a uniform electric field, which is identical strength and direction in all places, a non-uniform electric field changes at different points. This non-uniform field causes cells to maneuver based on differences of their electrical properties in comparison with the fluid surrounding them, allowing researchers to separate and study them. While this system is widely used on Earth, it could allow researchers to explore its application in microgravity environments to more precisely manipulate particles and conduct research that isn’t feasible under Earth's gravity.

Tools similar to clinostats and dielectrophoresis offer a neater, cheaper and faster strategy to study the results of microgravites on cells in comparison with space missions. They are inexpensive and portable and require inexpensive equipment and a smaller sample volume to quickly generate reliable data.

https://www.youtube.com/watch?v=wbj3sbhumgw

Microgravity and cancer

While microgravity could cause cancer, it may additionally help researchers higher understand and treat cancer.

Cancer is some of the difficult diseases to treat since it develops rapidly and sometimes becomes immune to available treatments. By observing cancer cells in microgravity, researchers can study how they grow, divide and reply to drugs under different conditions. In easy terms, we take cancer cells out of their comfort zone to see how they react to an unknown environment.

For example, researchers have observed that cancer cells have Improved survival under microgravity. They also saw changes to their electrical properties. Other studies have shown that microgravity can Alter immune cell function and the way cells communicate with one another.

Our team and others assume that cancer cells can respond more effectively to certain medications when exposed to a weightless environment. We are exploring whether we will use microgravity to govern cancer cells to behave less aggressively and turn out to be more liable to treatment.

This research continues to be in its infancy. However, if these findings could help researchers develop latest treatments that might be more practical here on Earth again.

Millions of individuals within the United States and around the globe suffer from urinary tract infections yearly. Some groups are special susceptible to chronic urinary tract infectionsincluding women, older adults and a few veterans.

These infections are often treated with antibiotics, nonetheless excessive use of those medications may cause the microbes they aim to grow to be resistant and reduce the effectiveness of the drugs.

To solve this problem of chronic urinary tract infections and antibiotic resistance, we’ve got pooled our expertise in microbiology and engineering to create a living material that harbors a certain style of useful substance. Our research shows that the “Good” bacteria are released from this biomaterial can compete with “bad” bacteria for nutrients and win, dramatically reducing the variety of disease-causing microbes.

We consider that, if further developed, this system could help treat recurrent UTIs that don’t reply to antibiotics.

Brings bacteria into the bladder

Nutrients are limited for the microbes living in humans and their abundance varies depending on the a part of the body. Bacteria need to compete with other microbes and the host to acquire vital nutrients. By absorbing available nutrients, helpful bacteria can do that Stop or slow the expansion of harmful bacteria. When harmful bacteria lack vital nutrients, they can not grow in sufficient numbers to cause disease.

However, helpful bacteria are added to the bladder to stop urinary tract infections. On the one hand, these helpful bacteria can only colonize naturally in individuals who do unable to completely empty her bladdera condition called urinary retention. Even in these patients, the length of time these bacteria can colonize their bladder varies greatly.

Current methods of delivering bacteria into the bladder are invasive and require repeated insertion of the catheter. Even if bacteria are successfully released into the bladder, Urine will flush out these microbes because they can not adhere to the bladder wall.

Biomaterials for the treatment of urinary tract infections

Because helpful bacteria cannot attach and survive within the bladder for long, we developed a biomaterial that may slowly release bacteria within the bladder over time.

Our biomaterial consists of life embedded in a matrix structure manufactured from gel. It resembles a chunk of jelly about 500 times smaller than a drop of water and might release bacteria into the bladder for as much as two weeks. Supplying the bacteria via biomaterial eliminates the necessity for the bacteria to connect to the bladder with the intention to remain within the organ.

We tested our biomaterial by placing it in human urine in petri dishes and exposing it to bacterial pathogens that cause urinary tract infections. Our results showed that with a 50:50 mix the displaced the bacteria that cause urinary tract infections by increasing to around 85% of the whole population. If we added greater than urinary tract infection-causing bacteria, which we envision for future development and testing, the proportion rose to over 99% of the population, essentially wiping out the urinary tract infection-causing bacteria. In addition, the biomaterial continued to be released in human urine for as much as two weeks.

Our results suggest that they’ll remain and survive within the bladder for an prolonged time frame successfully curb growth of many forms of bacteria that cause urinary tract infections.

Improve biomaterials

Our results show that not only harmful bacteria, to which it’s closely related, will be controlled, but additionally a wide spectrum of pathogenic bacteria in humans and animals. This implies that scientists may not have to discover several types of helpful bacteria to combat every pathogen – and there are various – that may cause a urinary tract infection.

Our team is currently investigating how effectively our biomaterial can cure urinary tract infections in mice. We are also working to discover the particular nutrients that helpful and harmful bacteria compete for, and what aspects may also help helpful bacteria win. We could add these nutrients to our biomaterial to release or retain them.

This research continues to be in its early stages and clinical application shouldn’t be yet under development. So if it reaches patients, things will go well in the long run. We hope that our technology will be refined and used to combat other bacterial infections and a few others Cancers attributable to bacteria.

Citrus trees which have a natural tolerance to citrus greening disease harbor bacteria that produce novel antimicrobial agents that might be used to combat the disease. Our current study shows. We found the trees on an organic farm in Clermont, Florida.

Citrus Greening Disease – higher often known as Huanglongbing or HLBis brought on by the bacterium Candida Liberibacter asiaticus. It is spread through an insect called the Asian citrus psyllid. There isn’t any known cure for the disease.

We are Researchers from Florida who study sustainable agricultural practices, a discipline also often known as agroecology. Our team has isolated these antimicrobial compounds within the laboratory and is now working to check them with the goal of developing an efficient treatment for HLB.

Why it matters

HLB has dealt a significant blow to Florida's legendary citrus industry.

Since Citrus greening disease was first discovered within the state of Florida in 2005 Citrus production has fallen by greater than 92%. The illness is only one factor. Others are hurricanes and frost.

Infected trees produce less fruit. The fruits that grow are partly green, smaller, irregularly shaped and taste bitter. It may fall from trees before maturity. The leaves can have mottled spots.

According to the U.S. Department of Agriculture, the growing season was 2022-2023 the least productive since 1936. Smaller harvests result in higher prices for oranges, tangerines, grapefruits, lemons and limes.

Management of HLB is daunting. Breeder currently depend on pesticides to manage psyllium and Antibiotics comparable to oxytetracycline in an attempt to manage HLB. These treatments are expensive and might be hazardous to health And Environmental risks. The have to develop effective treatments to manage HLB is clear.

How we did our work

Like people, Plants harbor diverse communities of microorganisms each inside and out of doors and represent the plant microbiome.

Endophytes – helpful microorganisms life in plants – play a vital role in nutrient absorption, disease and pest resistance and adaptation to environmental stress.

In searching for treatments for HLB, we checked out endophytes from surviving citrus trees – in other words, trees that were HLB positive but showed only mild symptoms and continued to bear fruit. By examining 342 endophytes from surviving trees, we discovered five bacterial endophytes capable of manufacturing novel antimicrobials.

The HLB bacteria can’t be cultured Laboratory culture media like agar or broth. Therefore, we used live bacterial cells present in the soil tissue samples of infected psyllids to check the antimicrobial compounds within the laboratory. These studies found that they were antimicrobial compounds highly effective in killing living cells of the citrus greening pathogen this controlled environment. The antimicrobials might be mixed with water and have been shown to be effective even in low concentrations.

What isn’t yet known

Preliminary results from our ongoing work suggest that multiple antimicrobial compounds are present within the bacterial culture extract. This is a positive sign since the antimicrobial compounds are found to attack pathogenic bacteria in quite a lot of ways. If that's the case, it’s going to help minimize the event of resistance, just as various antibiotics are useful to human doctors.

One of our next steps will likely be to judge chosen compounds against HLB using infected citrus roots under laboratory conditions and infected citrus plants under greenhouse conditions to check whether the plants absorb these antimicrobial compounds through their leaves or roots. This work is being conducted in collaboration with scientists at Texas A&M University and the University of Florida.

What's next?

Further research will concentrate on methods to extend the production of purified antimicrobial compounds in order that they might be evaluated in the sphere. To bring the technology to farmers more quickly, we may seek partnerships with interested business biopesticide corporations to help us in product development.

Our work has taken on latest urgency on account of emerging aphid-borne diseases that infect Potato, tomato and carrot crops within the United States, that are brought on by closely related bacterial pathogens.

The Research Brief is a temporary insight into interesting scientific work.

At a pharmacy in Iowa, a 42-year-old gay black man couldn't find a medicine he needed. The pharmacist, a white woman, told him they didn't have that medication in stock. But while he was waiting to pay for his other purchases, he saw one other customer put the medication he had just ordered on the counter.

“I felt really bad,” he said. “I think when people associate their prejudices with their profession, it makes it harder to access (health) services.”

These services include PrEP or Pre-exposure prophylaxisa highly effective prescription medicine that stops the spread of HIV.

Black gay and bisexual men about 38% of the estimated 37,981 latest HIV diagnoses within the United States in 2022. The Centers for Disease Control and Prevention estimate that About 50% of those men will receive an HIV diagnosis during their lifetime.

Although black gay and bisexual men are disproportionately affected by HIV, they’ve considered one of the lowest PEP usage rates in all age groups. Many of them live within the South, where most individuals living with HIV live within the United States, but PrEP uptake may be very low on account of stigma, cost, and homophobia. Other barriers include lack of trust within the health care system, discrimination, poverty, and lack of information amongst doctors about PrEP.

PrEP faces significant barriers to widespread use amongst probably the most vulnerable populations. In 2022 36% of the 1.2 million people who may benefit from PrEP were prescribed the medication. Public health researchers study why Black gay and bisexual men have low access to PrEP in Iowa – a rural state with rising HIV infection rates, particularly amongst sexual and gender minorities. We recently published a study that highlighted Some ways to enhance prevention.

Trust and discrimination

Non-Hispanic blacks make up only 4% of Iowa’s estimated 3.1 million residents. However, they made up 24% of individuals in Iowa might be living with HIV in 2022.

A report from the Iowa Department of Health and Human Services found that just over 23% of individuals in Iowa who need PrEP had lively recipes in 2021Another report found that a government program called TelePrEP, which goals to expand access to PrEP through telemedicine, significant differences in the beginning of treatmentOnly 10% of people that began PrEP through this system were black. In contrast, 83% of those that began TelePrEP were white.

To higher understand the aspects that make it difficult or easier for black gay and bisexual men in Iowa to access PEP, interviewed 12 HIV-negative community members about their experiences with the drug. They ranged in age from 20 to 42 and lived in Johnson and Black Hawk counties, which have a few of the highest HIV infection rates within the state. We recruited them through dating apps, social media platforms and native organizations.

Some men feared that using PrEP could lead on to mistrust of their intimate relationships.

“[F]or you enter into a sexual relationship with a partner, there has to be a certain level of trust,” said one participant. “The fact that you have to take drugs before engaging in sexual activity shows that you do not trust your partner.”

Other men feared they’d be stigmatized and discriminated against. Some people within the gay community associate taking PrEP with sexual promiscuity and are subsequently afraid of being judged for taking the drug.

“If you don’t have sex, why should you take PrEP?” asked one participant.

Some men also had negative experiences with the health care system, including being denied access to medication due to their race.

Most men felt that inadequate medical insurance was a significant barrier to PrEP use. Five of our participants had no medical insurance and only two had public medical insurance. Some of the participants were students and had limited access to non-public insurance.

“There are a lot of people who are uninsured,” said one participant. “It would be nice if the government could actually make it accessible to everyone – just like the HIV self-test.”

Many of the lads had little or no prior knowledge of PrEP. “Yes, I don't know much about PrEP,” said one participant. “That's actually why I decided to take part in this study, to actually learn more about it.”

Some men were afraid of the possible uncomfortable side effects of the drugs. One participant was concerned in regards to the risk of developing cancer from long-term use of the drugs. There are no evidence that PrEP increases the danger of cancer, but a An HIV infection can.

Finally, some men also fearful about how effective the drugs were and whether or not they could depend on them if their partner was HIV-positive. However, when taken appropriately, PrEP can Reduce the danger of sexually transmitted HIV infection by about 99%.

Populations surveyed for other studies expressed similar concerns about treatment, including Transgender women in Colombia And gay and bisexual men within the Midwest of the USA.

Improving access to PrEP

Despite the numerous barriers faced by gay and bisexual black men in Iowa in accessing PrEP, possible solutions highlighted.

Most of our participants agreed that educating the general public about PrEP and raising public awareness about health issues is crucial. “You could reach people through the radio and flyers. You could put them out at the hairdresser, the barbershop, the supermarket,” one participant suggested. “I think those are public places that are really accessible to people.”

Some emphasized the importance of developing culturally sensitive educational programs on different platforms to raised engage the community. One participant said, “Doing seminars and focus group discussions and educating people about PrEP could really help.”

Participants also suggested that making PrEP available no matter insurance status would help reduce financial barriers to accessing this preventive medication. For example, free or low-cost access to all types of PrEP could possibly be a game-changer, especially for low-income people in danger for HIV.

Our participants also emphasized the role that trusted physicians could play.

“To convince me to start something like PrEP, it would have to come from someone I already trust,” said one participant. “Their expertise and personal knowledge of my health condition would make their advice particularly compelling.”

As diagnoses of autism spectrum disorders have increased over the past twenty years, so has the variety of experimental and off-label therapies to treat this condition.

For parents who must navigate the complex and infrequently conflicting landscape of autism interventions—while juggling doctor appointments, educational professionals, and countless other family needs—evaluating these treatments could be daunting.

Autism research experts spoke to the Times about what parents and patients should search for when evaluating a possible recent treatment – for autism or another condition.

Take testimonials with caution

Firsthand accounts of the life-changing effects of a therapy could be very compelling. But such stories alone cannot provide insight into how effective a treatment shall be for others, autism experts say.

“Be wary of therapies that are sold to you with testimonials. If you go to a clinic's website and there are dozens of quotes from parents saying, 'This changed my child's life in XYZ ways,' that's not proof,” says Zoe Gross of the Autistic Self Advocacy Network, a nonprofit group of and for autistic adults. “If something is promoted primarily through testimonials, it may be because there is no research, or the research that has been done has shown it is not effective.”

Without accompanying data, it's unimaginable to find out whether a patient's experience with a treatment is typical or an outlier. A therapy could have only a 1% success rate, Gross said, and yet produce dozens of positive results after hundreds of individuals try it.

Doctors say the stories of former patients is usually a start line for locating out whether therapy is correct for somebody. But the exploration shouldn't end there.

“There is an old saying in medicine,” said Dr. Andrew LeuchterDirector of the TMS Clinical and Research Service at UCLA. “The plural of anecdote is not data.”

Search for – and see – the research

“It's really sexy right now to call yourself 'evidence-based,'” said Dr. David Celiberti, executive director of the nonprofit Assn. for Science in Autism Treatment. “For a consumer, that's great. When you hear 'evidence-based,' you're naturally drawn to it. But people use that term very loosely.”

In the case of magnetic resonance therapy, or MERT, its developer Wave Neuroscience offers a library of ResearchSimilar links could be found on the web sites of many licensed clinics.

Most of the autism publications cited by MERT clinics – and sometimes by Wave – are either limited in scope or only tangentially related to therapy, said half a dozen experts, including some whose work is cited.

One of them is, for instance, a brief article from 2016 from the Austin Journal of Autism and Related Disabilities entitled “The Potential of Magnetic Resonance Therapy in Children with Autism Spectrum Disorder.”

The authors and consultants said they were surprised to learn the paper was getting used to advertise the treatment. The paper comprises no data or original research and easily concludes that MERT could be further studied as an autism therapy without risk of great harm.

“This is not an evidence-based article. It is an opinion piece about the possibilities of this technology,” said Dr. John CrawfordNeurologist at Children's Hospital of Orange County and co-author of the study. “From a scientific point of view, it's not that significant.”

Who else has confirmed these results?

Many MERT clinics have a 2014 electronic poster presentation The project examines data from the medical records of 141 children who received transcranial magnetic stimulation for autism, the therapy on which MERT is predicated.

Until MarchWave posted the poster on its website, highlighting that 59.1% of the 44 participants who accomplished 12 months of treatment improved their scores on the Childhood Autism Rating Scale, an assessment tool used to measure symptom severity.

A more in-depth take a look at the report shows that after five days of treatment, 38 patients were excluded from the evaluation because their symptoms either showed no improvement or worsened. One suffered a seizure during treatment.

The authors excluded dozens more patients for various reasons. Of the remaining 44 patients, 26 showed improvement during treatment. That was 59.1% of those remaining, in keeping with the poster, but only 18.4% of the whole study population.

The report also notes that lots of these 26 children were receiving other therapies at the identical time, which could have been accountable for some or all the improvements.

Posters are typically created to focus on findings at skilled conferences and “cannot be considered to have undergone rigorous peer review,” says neurosurgeon Dr. Charles Liu of USC, a co-author of the poster who just isn’t affiliated with Wave or any MERT clinic.

“The primary point of the abstract is and stays that more rigorous studies are needed [be] Completed.”

If tests show changes, how do you know that the therapy caused them?

Wave and licensees also emphasize a paper from 2022 by a technician from a licensed clinic in Australia who is also a PhD student at the University of the Sunshine Coast in Australia.

The study examined data from 28 patients from two MERT clinics in Australia whose brains showed a “significant improvement” in their individual alpha frequency waves after treatment.

Although previous studies have found a link between the atypical frequency of alpha waves and autism diagnoses, six scientists told the Times that there is not yet enough evidence to understand how changes in alpha waves affect autistic traits, and there is no scientific consensus on whether “improving” this pattern of brain activity has any meaningful effect on autistic behavior.

The report is a retrospective chart review that examines existing data from patients' medical records and is usually used to discover interesting findings worthy of further investigation.

By design, the study doesn’t include a control group, which allows researchers to find out whether the observed changes are related to the variable under study. The authors identified of their article that the outcomes are preliminary and require further investigation.

“Since this was not a controlled study, [the cause of the changes] “The cause could have been anything, including a placebo effect, any additional therapies the children were receiving, etc.,” said Lindsay Oberman, director of the Neurostimulation Research Program at the National Institute of Mental Health.

Medical research follows a hierarchy of evidence. At the bottom are anecdotes and observations: valid information that alone is not enough to draw comprehensive conclusions.

In addition, there are observational studies that systematically collect and analyze existing data. And at the top are randomized controlled trials, which are designed to exclude as many biases as possible from the experiment and to ensure that the object being studied is responsible for all observed changes.

“Families need to know that there is this gold standard for studies – to make sure that something works to help people with autism, there has to be what’s called a randomized controlled trial,” said Alycia Halladay, scientific director of the Foundation for Autism Research.

©2024 Los Angeles Times. Visit www.latimes.com. Distributed by Tribune Content Agency, LLC.

Originally published: September 13, 2024 at 1:25 p.m.

When the Indian Health Service cannot provide medical care to Native Americans, the federal agency can refer them elsewhere. But every year it turns down tens of 1000’s of requests for funding for these treatments. Patients are forced to either forgo treatment or pay the horrendous medical bills out of their very own pockets.

Theoretically, Native Americans are Right to free health care when the Indian Health Service foots the bill for its facilities or sites managed by tribes. In reality, the agency chronically underfunded Medical care is proscribed and enormous parts of the country do not need easy accessibility to medical care.

The Purchase/Referred Care program is designed to fill gaps by paying outside providers for services that patients can't get at an agency-funded clinic or hospital, reminiscent of cancer treatment or prenatal care. But resource constraints, complicated regulations and administrative blunders make the referral program much harder to access, say patients, elected officials and other people who work with the agency.

The Indian Health Service, a part of the Department of Health and Human Services, serves roughly 2.6 million American Indians and Alaska Natives.

Native Americans qualify for the referral care program in the event that they continue to exist tribal land – only 13% — or inside the “Delivery area”, which usually includes surrounding counties. Those living in one other tribe’s delivery area are eligible in limited cases, while Native Americans living beyond those boundaries are excluded.

However, eligible patients don’t have any guarantee of monetary assistance or timely help. Some of the Indian Health Service's 170 service units have exhausted their annual pot of cash or are reserving it for essentially the most serious medical problems.

In fiscal yr 2022, referral programs denied or deferred nearly $552 million in spending for about 120,000 eligible patient claims.

This may cause Native Americans to forgo health care, increasing the danger of death or serious illness for individuals with preventable or treatable conditions.

The problem will not be latest. Federal regulators have reported concerns with this system for many years.

Connie Brushbreaker, a member of the Rosebud Sioux Tribe, has been denied funding or placed on a waiting list at the very least 14 times since 2018. She says it is unnecessary that the agency sometimes refuses to pay for treatment that is just approved later when a health problem becomes more serious and expensive.

“We try to prevent it before it gets to the point where surgery is needed,” says Brushbreaker, who lives on her tribe’s reservation in South Dakota.

Many Native Americans imagine the U.S. government is violating its treaties with tribal nations, which regularly promised tribes would receive take care of their health and well-being in exchange for surrendering their land.

“My elders here keep telling me, 'There are treaty rights that say they can provide us with these services,'” said Lyle Rutherford, a council member of the Blackfeet Nation in northwest Montana who also said he worked for the Indian Health Service for 11 years.

Native Americans have a high rate of disease in comparison with the final population and their average age of death is 14 years younger than that of whites. Researchers who investigated the subject say many problems are the results of colonization and government policies, reminiscent of forcing Native people into residential schools and isolated reservations and abandoning healthy traditions reminiscent of bison hunting and non secular ceremonies. They also point to a persistent lack of health funding.

Congress has appropriated nearly $7 billion to the Indian Health Service this yr, with about $1 billion earmarked for the referral program. A committee of tribal health and government leaders has long made funding recommendations that far exceed the agency's budget. His latest report According to the Indian Health Service, $63 billion is required for fiscal yr 2026 to fulfill patient needs, including $10 billion for referrals.

Improving the referral program is a priority for the Indian Health Service, based on Brendan White, a spokesman for the agency. He said that this yr, about 83% of the health facilities it manages were capable of approve all eligible funding requests.

White said the agency recently How referred care Programs prioritize such requests, and there are staff shortages that may slow the method. An estimated one-third of the positions within the referred care program were unfilled in June, he said.

The Indian Health Service recently expanded some delivery areas to incorporate more people and studied whether it may possibly afford to introduce statewide voting rights within the Dakotas.

Jonni Kroll of the Little Shell Chippewa Indian Tribe in Montana doesn’t qualify for the referral care program because she lives in Deer Park, Washington state, nearly 400 miles from her tribe's headquarters.

She said linking eligibility to tribal lands was a mirrored image of old government policies geared toward keeping indigenous people in a single place, even when it meant limited access to jobs, education and health care.

Kroll, 58, said she sometimes worries in regards to the medical costs of aging and that moving to qualify for this system is unrealistic.

“We have people living all over the country,” she said. “What are we going to do? Sell our homes, leave our families and our jobs?”

People who apply for funding must face a system so complicated that the Indian Health Service created flowcharts outline the method.

Misty and Adam Heiden of Mandan, North Dakota, have experienced this primary hand. Their nearest Indian Health Service hospital not offers maternity care. Late last yr, Misty Heiden asked the referral of care program to cover the associated fee of delivering her baby at an out of doors facility.

Heiden, 40, is a member of the Sisseton-Wahpeton Oyate, a tribe native to South Dakota, but lives within the delivery territory of the Standing Rock Sioux Tribe. Native Americans who, like her, live within the territory of one other tribe are eligible in the event that they have close ties. Although she is married to a tribal member from Standing Rock, Heiden was deemed ineligible by hospital staff.

Now the family needed to cut their food budget to pay their medical bills of over $1,000.

“It was like a slap in the face,” said Adam Heiden.

White, the Indian Health Service spokesman, said many providers offer Teaching materials to assist patients understand eligibility. But the Standing Rock Rulesshould not fully explained within the brochure.

If patients are eligible, their needs might be assessed using a medical priority list.

Connie Brushbreaker's doctor on the Indian Health Service Hospital in Rosebud, South Dakota, said she needed to see an orthopedic surgeon. But Hospital staff said the unit only cares for patients who’re at immediate risk of death.

She said that at one point, a referral program employee told her that she could manage her pain, however the pain was so severe that she needed to limit her work duties and depend on her husband to place her hair in a ponytail.

“I feel like I’m being pushed aside, like I’m not important,” Brushbreaker wrote in an appeal letter“I ask you to reconsider.”

The 55-year-old finally received funding approval and underwent surgery in July of this yr, two years after her shoulder injury and 4 months after the referral.

Patients reported that they generally had difficulty reaching referring departments attributable to staffing issues.

Patti Conica, a member of the Standing Rock Sioux Tribe, required emergency care in June 2023 after contracting a serious infection. She said she applied for funding to cover the prices but has yet to receive a choice in her case despite repeated phone calls with referred care staff and in-person visits.

“I was kept waiting,” says Conica, 58, who lives in Fort Yates, North Dakota, her tribe’s headquarters.

She now has to pay greater than $1,500 in medical bills, a few of which have been turned over to a set agency.

Tyler Tordsen, a Republican state representative and member of the Sisseton-Wahpeton Oyate in South Dakota, says the referral treatment program needs more cash, but officials could also “manage their finances better.”

Some service units have large quantities of Remaining funds. However, it’s unclear how much of this money has not been spent and the way much is earmarked for approved cases which can be currently being billed.

In the meantime, more tribes manage their health care facilities – an arrangement that also uses agency funds – to try latest ways to enhance services.

Many also attempt to help patients receive outside care in other ways. These may include providing free transportation to appointments, arranging visits from specialists on reservations, or creating tribal communities. Health insurance programs.

For Brushbreaker, begging for funding felt “like selling my soul to the gods of the IHS.”

“I’m just tired of fighting the system,” she said.

Subscribe for the free Morning Briefing from KFF Health News.

Originally published: September 9, 2024 at 1:26 p.m.

Hundreds of thousands and thousands People everywhere in the world suffer from chronic pain – this implies persistent pain longer than three months. Although the figures vary from country to country, most studies assume that about 10% of the world population This affects greater than 800 million people.

The Centers for Disease Control and Prevention estimate that in 2021, about 20% of adults within the United States – or greater than 50 million people – have chronic painOf these, about 7% experienced what’s severe chronic painPain that significantly limits an individual’s each day activities.

In the past, doctors were quick to prescribe medication as a straightforward solution. But the Opioid crisis within the USA has caused doctors to rethink their reliance on medications and look for brand spanking new treatments for patients with chronic pain.

The Conversation spoke to Rachael Rzasa LynnA Specialist in pain therapy from the University of Colorado Anschutz Medical Campus for our podcast The Conversation Weekly. She explains a few of the latest developments in pain management and why there may be hope for patients with chronic pain.

What is the fundamental reason behind chronic pain?

In general, pain is a fancy interplay between tissue injury or inflammation, nerves and brain processes.

There are several biological processes that may cause pain. The process that happens in most individuals after they experience acute pain is named nociceptive pain. This pain occurs when tissue is injured or damaged not directly, triggering the activation of surrounding nerves. These nerves are like electrical wires that send signals from the injured tissue through the spinal cord to the brain, where the pain is ultimately perceived.

But the activation of those nerves alone doesn’t mean that pain occurs, because these electrical signals are amplified or weakened at several points on their technique to the brain. The brain's perception of pain is crucial, because pain doesn’t occur when persons are unconscious.

Nociceptive pain can be brought on by persistent tissue injury or inflammation, as within the Case of arthritisIn these injuries, the peripheral nerves chronically transmit signals to the brain, leading to persistent pain perception.

There are other disease processes, similar to diabetic peripheral neuropathywhere the nerves themselves are injured. In these cases, the nerves send pain signals to the brain that reflect an injury to the nerves themselves, to not the tissue from which they originate. This is named Neuropathic pain.

In other types of chronic pain, the so-called nociplastic painThe initial tissue injury can completely heal, however the brain and nervous system proceed to generate pain signals.

In fact, many chronic pain conditions involve a mixture of all three phenomena – nociceptive, neuropathic and nociplastic pain – which further complicates diagnosis and treatment.

How do doctors such as you measure pain?

I feel anyone who has been in a hospital within the last decade, not less than within the United States, is acquainted with the numerical scale on which they must rate their pain. It's a one-dimensional pain assessment that just asks how much pain you might have.

But pain is a really complex phenomenon, with many more features than simply the severity of the pain. So a single numerical value based on the severity of the pain ignores the impact that pain can have on a patient's each day life, similar to their activities, their relationships, their ability to sleep, their happiness and their overall satisfaction with their life.

I feel the toughest thing about all pain, but especially many types of chronic pain, is you can't see it. There isn’t any external, validated technique to really understand how much pain someone is in. While we’ve got newer ways of measuring pain that attempt to capture a few of these more complex features, it's still a really incomplete science. It's still all subjective and based on what the patient tells you about their experience.

Which latest pain treatment options are most promising?

A brand new popular treatment is named Pain reprocessing therapywhich takes a behavioral approach to pain relief.

Here at our medical campus, therapists help patients understand the causes of chronic pain after which reappraise the sensations they perceive as painful – similar to typically painful movements. The goal of pain processing therapy is to assist patients perceive the pain signals sent to their brain as less threatening, so their brain “unlearns” the pain.

Another approach that’s being applied in a brand new way is Nerve ablationa procedure during which the nerves around a painful area are numbed with drugs after which intentionally damaged. In these cases, doctors inject a chemical across the nerves or gently heat them in order that they’ll now not send pain signals for months and even years. This approach has been used for a long time for back pain, but is now getting used for pain in other areas of the body as well.

An identical approach is to stimulate the nerves that offer a painful area with electricity to vary or block the best way pain signals travel through them. In this method, a tiny electrical device is placed next to the nerve to transmit the low level of current. This is an example of Neuromodulationwhich is increasingly getting used to treat a wide range of chronic pain conditions throughout the body, from foot pain to migraines. It has even shown promise in treating acute pain following surgeries similar to knee replacements.

A classic example of neuromodulation is spinal cord stimulation, which is used to treat a variety of chronic pain conditions. It involves a surgeon placing wires beneath the bones of the back, but outside the spinal cord and spinal fluid. The wires are connected to a battery that, much like a pacemaker battery, sends electrical signals to the nerves within the spinal cord to decode the pain signals.

What role has the opioid crisis played?

These latest treatment options for patients with chronic pain may not have developed so quickly if it weren’t for the Opioid crisis.

For a long time, Opioids have been overprescribed for chronic pain. However, there are some patients with chronic pain for whom opioids really do profit when it comes to pain relief and quality of life. In my view, doctors have overcorrected somewhat, so it might now be difficult for these patients to access the opioid therapies that worked so well for them. Due partly to a slowdown in opioid production lately, many patients in some parts of the United States now not have access to those medications in any respect.

Therefore, researchers are actually working to develop latest drugs to alleviate pain without the addiction and overdose risks related to opioids. CannabinoidsIn recent years, the main target of patient care has shifted from drug treatment to behavioral and procedural interventions, including neuromodulation.

Looking to the long run: What’s next?

I feel the holy grail of pain medicine is to search out out which patients with the identical disease will reply to the identical treatment. For example, two patients with a degenerative tissue disease like arthrosis of the knee can have almost an identical x-rays, yet the perception of pain and response to treatment may be completely different. One patient may profit from physical therapy, while one other may not improve with physical therapy alone and will require multiple medications, injections, and eventually surgery – and should still must live with pain.

Researchers like me don't yet know what characteristics make one patient different from one other when it comes to these outcomes. This signifies that current treatment plans involve plenty of trial and error, which may be tedious and frustrating for patients in pain.

My goal and best hope for the long run of pain medicine is that researchers will find a greater technique to predict who will reply to a selected treatment so that they can match each patient with the appropriate treatment regimen the primary time.

Menopause was a taboo subject in lots of circles. Now it’s often within the news.

In March 2024, the White House announced an initiative to “spur new research on women’s health in midlife.” In May Senator Patty Murray presented bipartisan bill that may provide $275 million to enhance menopause care and midlife health.

The actor Halle Berry went to Capitol Hill to boost awareness of the measure. While she was there, she shouted: “I'm going through the menopause.”

The latest deal with menopause and the greater openness to speak about it takes place within the simultaneously with scientific studies emphasize the advantages of hormone therapy in treating menopausal symptoms – twenty years after it suddenly fell out of favor.

The three of us imagine that open discussions about menopause are long overdue. We write and teach about discrimination within the workplace, Ageing and the lawAnd feminism. After we joined forces to put in writing a book about Menopause and the lawWe are closely monitoring how researchers assess the advantages of hormone treatment and what impact this has on its availability.

Basics of menopause

Technically, Menopause is a time. It typically begins 12 months after the last menstrual cycle and marks the tip of fertility and typically occurs between the ages of 45 and 55. It is Perimenopause precedesa transitional phase wherein menstruation changes but continues and which might last as long as ten years.

People who’ve undergone menopause are in postmenopause for the remaining of their lives.

Menopause is a results of reduced production of estrogen and progesterone, two hormones produced within the ovaries. In the long run Estrogen loss also affects Bone density, cardiovascular system and other body parts.

Menopause also can occur early and abruptly, for instance after surgical removal of the uterus or ovaries.

Every yr greater than 2 million Americans reach menopause. Millions more are within the perimenopause at any time.

While The average age of menopause is 51 years.There are Variation along the breedethnic and income boundaries. As life expectancy increases, half of the population could one third of their lives in postmenopause.

Black women particularly are likely to experience menopause earlier than white women. Their Symptoms similar to hot flashesare more acute and these symptoms last moreHowever, black women are less prone to receive medical attention for these symptoms than white women.

What about perimenopause?

During perimenopausewhich generally begins after the age of 40, the body step by step stops producing estrogen – which frequently causes menopausal symptoms. It can hard to know whether someone is in perimenopause, as estrogen levels fluctuate and no definitive test to find out it.

The commonest symptoms Are Hot flashes and night sweats .

Other symptoms include Sleep disorderDepression, difficulty concentrating and vaginal dryness. Periods grow to be irregular and bleeding could also be heavier. Not every woman in menopause has symptoms – although 85% – and their severity varies.

Hormone treatment and controversy

Menopause Hormone therapyincluding estrogen alone and estrogen together with progesterone, has been prescribed for many years to treat these symptoms. Hormones have also been used to treat long-term risks related to menopause, including heart disease and osteoporosis.

By the yr 2000, approx. 1 in 4 women used hormone therapyThen, in 2002, the preliminary results of a study shook the medical world.

They got here from the Women's Health Initiativea placebo-controlled trial of menopausal hormone therapy that enrolled hundreds of ladies to research this treatment. Launched in 1991 by the U.S. government's National Institutes of Health, it stays the most important women's health prevention study ever conducted.

An interim evaluation from 2002 found that hormone therapy during menopause was related to an increased risk of Breast cancer, coronary heart disease and strokeDue to those results, the research was discontinued.

Within a number of months, using hormone therapy to treat menopausal symptoms decreased by almost halfThe proportion of all women taking these prescribed drugs fell to 4% inside twenty years and have become slow recovery Despite the growing recognition of Limitations of the 2002 study.

A more complex story about hormone therapy in menopause has emerged in recent times, along with a careful review of the conclusions resulting in the early termination of great parts of the the Women's Health Initiative study.

One problem is that the everyday age of Women who participated on this study were 63that’s, they were a few years beyond the perimenopause once they entered it.

Another reason was that the study focused on the role of hormones in Prevention of chronic diseasesreasonably than the relief of menopausal symptoms. A 3rd was that it just one form evaluated hormone treatment.

Treatment today

In line with this, many doctors today are increasingly prescribing hormone therapy for menopausal symptoms – especially for Women under 60 once they began taking it and whether their last period was inside the previous decade.

Hormone therapy will be in the shape of tablets, skin patches, gels or vaginal suppositories.

Tablets are convenient to take orally, while skin patches allow for consistent hormone delivery through the skin. Gels allow for simple application and absorption through the skin and offer flexibility in dosing. Vaginal suppositories act more directly on local symptoms similar to dryness and discomfort.

It can be available with synthetic or bioidentical Progesterone, even though it It just isn’t clear whether these versions are safer or more practical.

However, there are Patients with underlying diseases for whom hormone therapy is riskier than others and needs to be avoided, including patients with a history of breast cancer, other estrogen-sensitive cancers, and coronary artery disease, to call a number of.

In addition, latest non-hormonal treatments for decent flashes are currently being developed.

In 2023, the The Food and Drug Administration has approved fezolinetant, sold under the name Veozah. It is that first drug specifically developed to treat hot flashes and night sweats.

A second latest drug could come onto the market soon.

Antidepressants, epilepsy medications and other non-hormonal medications are also prescribed off-label to treat some menopausal symptoms.

Go forward

Unfortunately, many patients and even health care provider should not fully aware of the newest findings about effective treatments for menopausal symptoms.

The frequency of use of hormone therapy during menopause varies by race and ethnicity: white women have the very best rates, while Black and Hispanic women have the bottom. Without insurance, a month's supply of Generic estrogen costs about $29With insurance, the prices will be significantly lower.

All research shows that symptoms can’t be ignored and individualized treatment is vital. With latest openness to speak about and address menopause, in addition to potential research funding and latest treatments, we’re more optimistic that this inevitable stage of life will finally get the eye it deserves.